Recent

% | $
Quotes you view appear here for quick access.

iShares Silver Trust Message Board

petechamps21 9 posts  |  Last Activity: Apr 13, 2016 3:23 PM Member since: Dec 2, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    The ask is .5884

    by petechamps21 Apr 13, 2016 12:42 PM
    petechamps21 petechamps21 Apr 13, 2016 3:23 PM Flag

    I was right. A few hundred shares bought, brought the price up to .57.

  • petechamps21 by petechamps21 Apr 13, 2016 12:42 PM Flag

    That seems very high. Could that be the reason volume is low?

  • petechamps21 by petechamps21 Mar 29, 2016 5:01 PM Flag

    No one who owned the stock would make up false rumors, like saying the upfront is only $50K. They wouldn't be mad when the stock closed up at the end of the day. They wouldn't post several negative articles a day, every single day. They wouldn't complain about lack of PRs, and then also complain every time there is a PR. That would be stupid.

  • He said we would have 2 partnership agreements by the end of Q1 2016. Since he signed a tentative agreement for 3 drugs, we can say that's close enough. It would be great if IGXT can get a few million dollars upfront out of the agreement. Then if the 2nd Forfivo milestone is qualified for, there should be plenty of cash on hand to last until the next drug gets to market.

  • Reply to

    Golden Cross?

    by patricktully38 Mar 24, 2016 5:23 PM
    petechamps21 petechamps21 Mar 24, 2016 7:20 PM Flag

    Typically, the golden cross is when the 50 DMA crosses the 200 DMA. We are about 2 cents away from that, with the 50 DMA moving upward towards the 200 DMA. The 200 DMA is 52 cents. The 50 DMA is 50 cents. If the price remains where it is, or increases, it won't take very long. I was watching that, and disappointed when we fell below 50 cents on Wednesday. Nice that we bounced today.

  • Reply to

    Tough Day

    by petechamps21 Mar 23, 2016 6:40 PM
    petechamps21 petechamps21 Mar 23, 2016 10:13 PM Flag

    Pat, I fully expect a 20 PE at the minimum, when there are earnings. I also agree that the market will price in earnings ahead of time, when the partners sign, and the drugs are imminent. I don't see why the EU Riz is taking so long, or why no other countries have approved it. That seems like the only incremental potential source of sales revenue this year, That's also why the partnership deals are critical, if 2016 is going to be a good one for IGXT pps.

  • petechamps21 by petechamps21 Mar 23, 2016 6:40 PM Flag

    Hard to admit, but for today, Rags was right. Horst promised partnerships, and hasn't delivered them. No new products coming to market soon, so the upfront money is critical, especially now that expenses are somewhat higher than in the past. If you remember, Singular predicted break even for 2016. That's not bad. Starting to see why that makes more sense than the nine cents they were previously predicting. They also predicted a $1.50 pps by the end of the year. Hope that comes true.

    2018 sounds like the year where earnings start flowing. Not sure how the market will price the stock in the meantime. Lots of biotechs lose big bucks and carry large market caps based on potential. I'm still long, and staying. The upside should be great, just not sure when it will arrive. If they would sign Suboxone, Rizaport and Tadalafil partners, then everything would be looking sweet.

  • petechamps21 petechamps21 Mar 1, 2016 12:33 PM Flag

    If you read what you just wrote, it doesn't say that. You're making an assumption. 4/6s of the $2million will be received in Q!. Doesn't say when it will be recognized. I would prefer it's Q! actually. We want to maintain YOY growth.

  • petechamps21 petechamps21 Mar 1, 2016 8:37 AM Flag

    I don't think there is a portion of the 3M payment in the 4th quarter. I think the remainder goes into this quarter. If that's true, the 4th quarter could show a small loss, and then this quarter could show a gain. I'm not saying I remember for sure, and I didn't go back and read the transcript again, so don't rely on this. Maybe Patrick would know for sure. If there's no milestone payment included int the 4th quarter, it's unlikely there will be a profit.

SLV
15.59-0.08(-0.51%)May 23 4:00 PMEDT